Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40- year retrospective study in Croatia (CROSBI ID 319801)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Bašić-Jukić, Nikolina ; Borlinić, Tajana ; Tešanović, Deša ; Mokos, Ivica ; Lukić, Ivan Krešimir ; Bukvić Mokos, Zrinka Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40- year retrospective study in Croatia // Croatian medical journal, 63 (2022), 2; 148-155. doi: 10.3325/cmj.2022.63.148

Podaci o odgovornosti

Bašić-Jukić, Nikolina ; Borlinić, Tajana ; Tešanović, Deša ; Mokos, Ivica ; Lukić, Ivan Krešimir ; Bukvić Mokos, Zrinka

engleski

Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40- year retrospective study in Croatia

Aim To determine the prevalence of non-melanoma skin cancer (NMSC) and disease-specific risk factors in renal transplant recipients (RTRs). Methods This retrospective cohort study enrolled 1232 RTRs (736 men) treated in University Hospital Center Zagreb over 40 years. The effect of sex, age at transplantation, geographic residence, dialysis vintage, and the type of immunosuppressive therapy on NMSC occurrence was investigated. Results The prevalence of NMSC was 6.81%. Overall, 60.7% of patients developed basal cell carcinoma (BCC) and 30.9% of patients developed cutaneous squamous cell carcinoma (cSCC). Only 8.3% developed both tumors. The BCC:cSCC ratio was 1.76:1. The risk for NMSC was 50% higher in men. Patients older than 50 years at transplantation were at greater risk for NMSC development. Residence in an area with higher ultraviolaet radiation (UV) exposure and dialysis vintage before transplantation did not influence NMSC development. Cyclosporine and azathioprine treatment conferred a greater risk for NMSC than tacrolimus or mycophenolate mofetil treatment. Conclusion RTRs are at high risk for NMSC development. Sex, age at transplantation, and type of immunosuppressive therapy play a role in tumor development.

kidney transplantation ; non-melanoma skin cancer

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

63 (2)

2022.

148-155

objavljeno

0353-9504

10.3325/cmj.2022.63.148

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost